Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs

Article ID	Journal	Published Year	Pages	File Type
5843113	Pharmacological Research	2016	27 Pages	PDF

Keywords

CDK shell residue 1 K/E/D/D RS or R-spine pKa HR+PKC GRL PI3-kinase CIP/KIP CS or C-spine ER+INK4 WAF1 Hydrophobic activation segment catalytic loop ATP-binding site regulatory spine catalytic spine NSCLC Non-small cell lung cancer Breast cancer Sh1 phosphoinositide 3-kinase retinoblastoma protein protein kinase A Protein kinase C cyclin-dependent protein kinase estrogen receptor positive Progesterone receptor

Related Topics

Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Pharmacology

Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs

Authors

Robert Jr.,